Roland Stoughton - San Diego CA Julja Burchard - Kirkland WA Stephen H. Friend - Seattle WA
Assignee:
Rosetta Inpharmatics LLC. - Kirkland WA
International Classification:
C12Q 168
US Classification:
435 6, 435 911, 435 912, 536 231, 536 243
Abstract:
The present invention provides methods and systems, particularly computer systems, for determining the relative specificity with which a particular polynucleotide molecule hybridizes to a polynucleotide probe. For example, the methods and systems of the invention enable a user to compare the specificity with which different polynucleotides hybridize to a given probe and/or rank these polynucleotides according to their specificity to that probe. The methods and systems of the invention also enable a user to compare the specificity with which a particular polynucleotide hybridizes to different probes, and/or rank those different probes according to their specificity for that particular polynucleotide.
Computer Systems For Identifying Pathways Of Drug Action
The present invention provides methods and computer systems for identifying and representing the biological pathways of drug action on a cell The present invention also provides methods and computer systems for assessing the significance of the identified representation and for verifying that the identified pathways are actual pathway of drug action. The present invention also provides methods and computer systems for drug development based on the methods for identifying biological pathways of drug action, and methods and computer systems for representing the biological pathways involved in the effect of an environmental change upon a cell.
Roland Stoughton - San Diego CA Stephen H. Friend - Seattle WA
Assignee:
Rosetta Inpharmatics, Inc. - Kirkland WA
International Classification:
C12Q 100 G01N 3353 G06F 1714 C12N 1500
US Classification:
435 4
Abstract:
The present invention provides methods for identifying and representing the biological pathways of drug action on a cell by: (i) measuring responses of cellular constituents to graded exposures of the cell to a drug of interest; (ii) measuring the responses of cellular constituents to perturbations in one or more biological pathways of the cell; and (iii) scaling a combination of the measured pathway responses to fit the measured drug responses best according to an objective measure. In alternative embodiments, the present invention also provides for assessing the significance of the identified representation and for verifying that the identified pathways are actual pathway of drug action. In various embodiments, the effects on the cell can be determined by measuring gene expression, protein abundances, protein activities, or a combination of such measurements. In various embodiments, perturbation to a biological pathway in the cell can be made by use of titratable expression systems, use of transfection systems, modification to abundances of pathway RNAs, modifications to abundances of pathway proteins, or modifications to activities of the pathway proteins.
Methods For Predicting Age And Identifying Agents That Induce Or Inhibit Premature Aging
Columbian Elementary School Independence MO 1944-1950, Spring Branch Elementary School Independence MO 1950-1953
Community:
Danny Clark, Charlene Johnston, Pansy Sleeper, Ken Prater, Jpyce Halsey, Ron Lawson, Russell Cooksey, Mike Lucito, Karen Bradley, Connie Johnson, Patricia Smith
cystic fibrosis and those that cause severe skeletal malformations. The authors, led by Stephen Friend of the Icahn School of Medicine at Mount Sinai in New York, hypothesize that these 13 apparently normal adults have other genetic elements that compensate or buffer the effects of those mutations.
Date: Apr 12, 2016
Category: Health
Source: Google
'Genetic superheroes' are real and could lead to life-saving treatments – but nobody can talk to them
"There's an important lesson here for genome scientists around the world: the value of any project becomes exponentially greater when informed consent policies allow other scientists to reach out to the original study participants, said Stephen Friend, the other Resilience Project co-founder.
Dr. Stephen Friend, president of Seattles Sage Bionetworks, and his colleagues at the Icahn School of Medicine at Mount Sinai in New York, sifted through a massive data set pooled from a dozen previous genetic studies.
Date: Apr 12, 2016
Category: Health
Source: Google
Detailed Study Should Be Conducted On Those Who Escaped Genetic Disorders
According to a senior researcher Dr. Stephen Friend, if we find out as to how some children manage to escape their genetic composition, it would be instrumental in developing solutions for certain most horrible birth defects known to human race.
Date: Apr 12, 2016
Category: Health
Source: Google
'Buffer genes' may protect these 13 people from rare genetic diseases
The study is a first step in the Resilience Project, an effort led by Stephen Friend of Sage Bionetworks in Seattle, Washington, and Eric Schadt of the Icahn School of Medicine at Mount Sinai in New York City. They want to find healthy individuals who have genetic mutations that usually cause seriou
Date: Apr 11, 2016
Category: Health
Source: Google
13 amazing people somehow skirted genetic disaster
You can imagine the level of frustration, said the studys lead researcher, Stephen Friend, the president of the nonprofit Sage Bionetworks and a genomics professor at the Icahn School of Medicine at Mount Sinai in New York. It is almost as if you got to take the wrapping off the box but you coul
"If you want to develop therapies for prevention, if you want to come up with ways of not just finding the cause, but [also] ways of preventing the manifestations of disease," then these individuals may help find a way, Stephen Friend, a co-author of the study and a researcher at Sage Bionetworks in
Date: Apr 11, 2016
Category: Health
Source: Google
Why Do Some Kids Escape Terrible Genetic Disorders?
Figuring out how certain people are able to dodge their genetics could provide solutions to some of mankind's worst birth defects, said senior researcher Dr. Stephen Friend. He is the president of Sage Bionetworks, a nonprofit biomedical research organization in Seattle.